Solubility and Bioavailability Enhancement of a Novel Liquisolid Compact of Gliclazide

Bimal Debbarma *

Institute of Pharmacy, Assam Don Bosco University, Tapesia, Assam-782402, India.

Peter De Roux Sumer

Institute of Pharmacy, Assam Don Bosco University, Tapesia, Assam-782402, India.

Loushambam Samananda Singh

Institute of Pharmacy, Assam Don Bosco University, Tapesia, Assam-782402, India.

Kmensiful Binan

Institute of Pharmacy, Assam Don Bosco University, Tapesia, Assam-782402, India.

Waibiangki Lyngdoh

Institute of Pharmacy, Assam Don Bosco University, Tapesia, Assam-782402, India.

*Author to whom correspondence should be addressed.


The study investigates the use of liquisolid compacts, a revolutionary pharmaceutical formulation technique, to improve the dissolution rate of weakly water-soluble medicines, with gliclazide as a case study. Nonvolatile solvents such as polyethylene glycol (PEG) 400, tween 80, and propylene glycol were used to make liquidsolid tablets, together with carrier ingredients such as Avicel PH102, starch, or HPMC, and Aerosil 200 as a coating material. The drug-excipient interaction was studied utilizing techniques such as differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR). The produced tablets were tested for appearance, weight fluctuation, hardness, friability, drug content, and in-vitro drug release before being compared to traditional tablets (control) to determine the improvement in dissolution rate. The optimum formulation was subjected to stability tests. FTIR and DSC investigations revealed no significant drug-excipient interactions. All pill formulations met the requirements. Liquisolid tablets significantly increased gliclazide dissolving when compared to conventional tablets, which was ascribed to improved wetting qualities and particle effective surface area. According to the study, the liquisolid technique is a potential approach for increasing the dissolving rate of poorly soluble pharmaceuticals. The tablets remained stable at accelerated settings for three months, demonstrating the efficacy and feasibility of the liquisolid approach in increasing gliclazide dissolving rates.

Keywords: Gliclazide, liquisolid compact, carrier material, coating material

How to Cite

Debbarma, B., Sumer , P. D. R., Singh, L. S., Binan , K., & Lyngdoh , W. (2023). Solubility and Bioavailability Enhancement of a Novel Liquisolid Compact of Gliclazide. UTTAR PRADESH JOURNAL OF ZOOLOGY, 44(22), 207–217.


Download data is not yet available.


Shi Q, Li F, Yeh S, Moinuddin SM, Xin J, Xu J, Chen H, Ling B. Recent advances in enhancement of dissolution and super saturation of poorly water-soluble drug in amorphous pharmaceutical solids: A Review. AAPS PharmSciTech, 2022;23(1):16. Available:

Hadinugroho W, Martodihardjo S, Fudholi A, Riyanto S. Preparation of Citric Acid-Locust Bean Gum (CA-LBG) for the Disintegrating Agent of Tablet Dosage Forms. Journal of Pharmaceutical Innovation. 2022;17(4):1160–1175. Available:

Venkateswarlu K, Preethi JK, Chandrasekhar KB. Enhancement of loperamide dissolution rate by liquisolid compact technique. Advanced Pharmaceutical Bulletin. 2016;6(3):385–39 Available:

Chella N, Narra N, Rama Rao T. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan. Journal of Drug Delivery. 2014:1–10 Available:

Spireas SS, Jarowski CI, Rohera BD. Powdered solution technology: Principles and Mechanism. Pharmaceutical Research. 1992;09(10):1351–1358. Available:

Prajapati ST, Bulchandani HH, Patel DM, Dumaniya SK, Patel CN. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil. Journal of Drug Delivery. 2013: 1–9 Available:

Albayrak C, Barım G, Dag Ö. Effect of hygroscopicity of the metal salt on the formation and air stability of lyotropic liquid crystalline mesophases in hydrated salt–surfactant systems. Journal of Colloid and Interface Science. 2014;433:26–33. Available:

Kumar R, Thakur AK, Chaudhari P, Banerjee N. Particle size reduction techniques of pharmaceutical compounds for the enhancement of their dissolution rate and bioavailability. Journal of Pharmaceutical Innovation. 2022;17(2):333–352. Available:

Savjani KT, Gajjar AK, Savjani JK. Drug Solubility: Importance and Enhancement Techniques. ISRN Pharmaceutics. 2012:1–10. Available:

Wong SM, Kellaway IW, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. International Journal of Pharmaceutics. 2006;317(1):61–68. Available:

Kalepu S, Nekkanti V. Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharmaceutica Sinica B. 20155(5):442–453. Available:

Bhalani DV, Nutan B, Kumar A, Singh Chandel AK. Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines. 202210(9):2055 Available:

Gupta A, Hunt RL, Shah RB, Sayeed VA, Khan MA. Disintegration of highly soluble immediate release tablets: A Surrogate for Dissolution. AAPS PharmSciTech, 2009;10(2):495–499. Available:

Semalty A, Semalty M, Nautiyal U. Formulation and evaluation of mucoadhesive buccal films of enalapril maleate. Indian Journal of Pharmaceutical Sciences. 2010;72(5):571. Available:

Cheng X, Gao J, Li J, Cheng G, Zou M, Piao H. In Vitro-In Vivo correlation for solid dispersion of a poorly water-soluble drug efonidipine hydrochloride. AAPS PharmSciTech. 2020;21(5), 160. Available:

Gunawardhana LN, Al-Rawas GA, Kazama S. An alternative method for predicting relative humidity for climate change studies. Meteorological Applications. 2017;24(4):551–559.

Patel S, Kaushal AM, Bansal AK. Compression physics in the formulation development of tablets. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2006;23(1):1–66 Available: